Scandinavian BioPharma Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $19.8M
Latest Deal Amount
  • Investors
  • 3

Scandinavian BioPharma General Information

Description

Developer of pharmaceutical products designed to create vaccines and immunoglobulins. The company's offerings include the development of a new oral traveler's diarrhea vaccine, enabling doctors to help with the treatment of mild to moderate psoriasis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • Industrivägen 1
  • 171 48 Solna
  • Sweden
+46 08-470 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Scandinavian BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 20-Feb-2020 $19.8M Completed Generating Revenue
4. Grant 18-May-2017 00.000 Completed Generating Revenue
3. Secondary Transaction - Private Completed Startup
2. Seed Round Completed Startup
1. Corporate 23-Jun-2014 $675K Completed Startup
To view Scandinavian BioPharma’s complete valuation and funding history, request access »

Scandinavian BioPharma Executive Team (7)

Name Title Board Seat Contact Info
Björn Sjöstrand Co-Founder & Chief Executive Officer & Board Member
Peter Liss Chief Financial Officer
Mats Lidgard Co-Founder & Chairman
Lisa Sandberg Marketing Manager
Joacim Ölund Sales Manager
You’re viewing 5 of 7 executive team members. Get the full list »

Scandinavian BioPharma Board Members (3)

Name Representing Role Since
Annette Elmqvist Scandinavian BioPharma Board Member 000 0000
Mats Lidgard Scandinavian BioPharma Co-Founder & Chairman 000 0000
Nils Carlin Scandinavian BioPharma Vice President, Research & Development & Board Member 000 0000
To view Scandinavian BioPharma’s complete board members history, request access »

Scandinavian BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scandinavian BioPharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Vinnova Government Minority 000 0000 000000 0
Karolinska Institutet Endowment Limited Partner Minority 000 0000 000000 0
To view Scandinavian BioPharma’s complete investors history, request access »

Scandinavian BioPharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 03-Oct-2009 00 000000000000000 00.000 Pharmaceuticals
To view Scandinavian BioPharma’s complete investments history, request access »

Scandinavian BioPharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000 03-Oct-2009 00 000000000000000 00.000 Completed
  • 3 buyers
To view Scandinavian BioPharma’s complete exits history, request access »